Natural and Expanded CD4+ CD25+ Regulatory T Cells in Bone Marrow Transplantation

被引：10
作者：
Colonna, Lucrezia [1 ]
Sega, Emanuela I. [1 ]
Negrin, Robert S. [1 ]
机构：
[1] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 01期
关键词：
VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; IN-VITRO EXPANSION; EX-VIVO; CUTTING EDGE; IMMUNE RECONSTITUTION; DENDRITIC CELLS; SELF-TOLERANCE; CD4(+)CD25(+); IL-2;
D O I：
10.1016/j.bbmt.2010.10.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S58 / S62
页数：5
相关论文
共 57 条
[1]   Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin [J].
Basu, Samik ;
Golovina, Tatiana ;
Mikheeva, Tatiana ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5794-5798
[2]   Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].
Battaglia, M ;
Stabilini, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (12) :4743-4748
[3]   In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets [J].
Beilhack, A ;
Schulz, S ;
Baker, J ;
Beilhack, GF ;
Wieland, CB ;
Herman, EI ;
Baker, EM ;
Cao, YA ;
Contag, CH ;
Negrin, RS .
BLOOD, 2005, 106 (03) :1113-1122
[4]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[5]  
Brunstein C., 2009, ASH ANN M, V114, P513
[6]   Ex vivo expanded human CD4+CD25+Foxp3+regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD) [J].
Cao, Tinghua ;
Soto, Allis ;
Zhou, Wei ;
Wang, Weihong ;
Eck, Steven ;
Walker, Mindi ;
Harriman, Gregory ;
Li, Li .
CELLULAR IMMUNOLOGY, 2009, 258 (01) :65-71
[7]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[8]  
CHOI J, BLOOD, V116, P129
[9]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[10]   CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism [J].
Dai, ZH ;
Li, Q ;
Wang, YN ;
Gao, G ;
Diggs, LS ;
Tellides, G ;
Lakkis, FG .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (02) :310-317
123456